Literature DB >> 30599803

The Effect of a Cognitive Dual Task on the Control of Minimum Toe Clearance While Walking.

Daniel Hamacher1, Dennis Hamacher2, Roy Müller1,3, Lutz Schega2, Astrid Zech1.   

Abstract

The aim of the current study was to evaluate the effect of a cognitive dual task on minimum toe clearance (MTC) variability while walking. In a randomized cross-over design, gait kinematics of 25 older (70 ± 6 years) and 45 younger adults (25 ± 2 years) were captured during normal walking and dual-task walking. Variability of stride time, stride length, and MTC were calculated. Differences between normal versus dual-task walking were assessed using Wilcoxon tests. Compared with normal walking, dual-task walking caused an increase in stride time variability (older adults: p < .001 and younger adults: p < .001), while the variability of MTC decreased (older adults: p = .032 and younger adults: p = .012). MTC seems to be a task-relevant gait parameter that is controlled with high priority to preserve its variability under challenging conditions.

Keywords:  gait control; gait stability; gait variability; minimum foot clearances

Mesh:

Year:  2019        PMID: 30599803     DOI: 10.1123/mc.2018-0006

Source DB:  PubMed          Journal:  Motor Control        ISSN: 1087-1640            Impact factor:   1.422


  3 in total

1.  Less noise during dual-task walking in healthy young adults: an analysis of different gait variability components.

Authors:  Daniel Hamacher; Monique Koch; Susanna Löwe; Astrid Zech
Journal:  Exp Brain Res       Date:  2019-10-08       Impact factor: 1.972

2.  Walking barefoot vs. with minimalist footwear - influence on gait in younger and older adults.

Authors:  Evi Petersen; Astrid Zech; Daniel Hamacher
Journal:  BMC Geriatr       Date:  2020-03-04       Impact factor: 3.921

3.  Neural markers of proactive and reactive cognitive control are altered during walking: A Mobile Brain-Body Imaging (MoBI) study.

Authors:  David P Richardson; John J Foxe; Kevin A Mazurek; Nicholas Abraham; Edward G Freedman
Journal:  Neuroimage       Date:  2021-12-23       Impact factor: 6.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.